Ilse Meerschaut

Mrs. Ilse Meerschaut

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2017 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
IMIlse Meerschaut
Ilse Meerschaut
DRDaniel Rochefort
Daniel Rochefort
NRNicole Revençu
Nicole Revençu
JPJustine Pètre
Justine Pètre
CCChristina Corsello
Christina Corsello
BCBert Callewaert
Bert Callewaert
Background Mutations in forkhead box protein P1 (FOXP1) cause intellectual disability (ID) and specific language impairment (SLI), with or without autistic features (MIM: 613670). Despite multiple case reports no specific phenotype emerged so far. Methods We correlate clinical and molecular data of 25 novel and 23 previously reported patients with FOXP1 defects. We evaluated FOXP1 activity by an in vitro luciferase model and assessed protein stability in vitro by western blotting. Results Patients show ID, SLI, neuromotor delay (NMD) and recurrent facial features including a high broad forehead, bent downslanting palpebral fissures, ptosis and/or blepharophimosis and a bulbous nasal tip. Behavioural problems and autistic features are common. Brain, cardiac and urogenital malformations can be associated. More severe ID and NMD, sensorineural hearing loss and feeding difficulties are more common in patients with interstitial 3p deletions (14 patients) versus patients with monogenic FOXP1 defects (34 patients). Mutations result in impaired transcriptional repression and/or reduced protein stability. Conclusions FOXP1-related ID syndrome is a recognisable entity with a wide clinical spectrum and frequent systemic involvement. Our data will be helpful to evaluate genotype–phenotype correlations when interpreting next-generation sequencing data obtained in patients with ID and/or SLI and will guide clinical management.

9 October 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
IMIlse Meerschaut
Ilse Meerschaut
ABAude Beyens
Aude Beyens
WSWouter Steyaert
Wouter Steyaert
RRRiet De Rycke
Riet De Rycke
KBKatrien Bonte
Katrien Bonte
BCBert Callewaert
Bert Callewaert

1 January 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
IMIlse Meerschaut
Ilse Meerschaut
SCShana De Coninck
Shana De Coninck
WSWouter Steyaert
Wouter Steyaert
ABAngela Barnicoat
Angela Barnicoat
ABAllan Bayat
Allan Bayat
BCBert Callewaert
Bert Callewaert

11 September 2015 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
IMIlse Meerschaut
Ilse Meerschaut
VBVictoria Bordon
Victoria Bordon
CDCatharina Dhooge
Catharina Dhooge
PDPatricia Delbeke
Patricia Delbeke
AVArnaud V. Vanlander
Arnaud V. Vanlander
BCBert Callewaert
Bert Callewaert

10 March 2023 in Science Advances
Verified
Journal Article
Closed access
SSSarah E. Sheppard
Sarah E. Sheppard
LBLaura Bryant
Laura Bryant
RWRochelle Wickramasekara
Rochelle Wickramasekara
CVCourtney Vaccaro
Courtney Vaccaro
BRBrynn Robertson
Brynn Robertson
HSHolly Stessman
Holly Stessman
Pathogenic variants in KMT5B , a lysine methyltransferase, are associated with global developmental delay, macrocephaly, autism, and congenital anomalies (OMIM # 617788). Given the relatively recent discovery of this disorder, it has not been fully characterized. Deep phenotyping of the largest ( n = 43) patient cohort to date identified that hypotonia and congenital heart defects are prominent features that were previously not associated with this syndrome. Both missense variants and putative loss-of-function variants resulted in slow growth in patient-derived cell lines. KMT5B homozygous knockout mice were smaller in size than their wild-type littermates but did not have significantly smaller brains, suggesting relative macrocephaly, also noted as a prominent clinical feature. RNA sequencing of patient lymphoblasts and Kmt5b haploinsufficient mouse brains identified differentially expressed pathways associated with nervous system development and function including axon guidance signaling. Overall, we identified additional pathogenic variants and clinical features in KMT5B -related neurodevelopmental disorder and provide insights into the molecular mechanisms of the disorder using multiple model systems.

13 January 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
GCGerarda Cappuccio
Gerarda Cappuccio
Nicola Brunetti-PierriNicola Brunetti-Pierri
Nicola Brunetti-Pierri
PCPaul Clift
Paul Clift
CLChristopher Learn
Christopher Learn
JDJohn C. Dykes
John C. Dykes
ALAngela E. Lin
Angela E. Lin